Gunnar Telhammar
Director of Finance/CFO bei XINTELA AB
Profil
Mr. Gunnar Telhammar is a Chief Financial Officer at Targinta AB, a Chief Financial Officer at AcouSort AB, a Chief Financial Officer at Xintela AB, a Chief Executive Officer at BioFinans AB, a Chief Financial Officer at ImmuneBiotech Medical Sweden AB, a Chief Financial Officer at LifeAssays AB, a Chief Financial Officer at SensoDetect AB and a Chief Financial Officer at Tendo AB.
Mr. Telhammar was previously employed as a Chief Financial Officer by AegirBio AB, a Chief Financial Officer by BiBBInstruments AB, a Financial Manager by Telepartner AS (Norway), a Chief Financial Officer & Controller by Guard Therapeutics International AB, and a Chief Financial Officer by Preelumina Diagnostics AB.
He received his graduate degree from the University of Lund.
Aktive Positionen von Gunnar Telhammar
| Unternehmen | Position | Beginn |
|---|---|---|
| XINTELA AB | Director of Finance/CFO | 01.01.2013 |
| ACOUSORT AB | Director of Finance/CFO | 01.01.2016 |
| LIFEASSAYS AB (PUBL) | Director of Finance/CFO | - |
| TENDO AB | Director of Finance/CFO | - |
| SENSODETECT AKTIEBOLAG | Director of Finance/CFO | - |
ImmuneBiotech Medical Sweden AB
 ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Director of Finance/CFO | - |
| BioFinans AB | Chief Executive Officer | 01.01.2004 |
Targinta AB
 Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Director of Finance/CFO | 01.01.2019 |
Ehemalige bekannte Positionen von Gunnar Telhammar
| Unternehmen | Position | Ende |
|---|---|---|
| Telepartner AS (Norway) | Director of Finance/CFO | 01.01.1996 |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Ausbildung von Gunnar Telhammar
| University of Lund | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 7 |
|---|---|
| SENSODETECT AKTIEBOLAG | Commercial Services |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| ACOUSORT AB | Distribution Services |
| XINTELA AB | Health Technology |
| BIBBINSTRUMENTS AB | Health Technology |
| AEGIRBIO AB | Health Technology |
| TENDO AB | Health Technology |
| Private Unternehmen | 6 |
|---|---|
LifeAssays AB
 LifeAssays AB Medical SpecialtiesHealth Technology LifeAssays AB is a diagnostic company, which engages in the provision of point-of-care diagnostic testing for veterinarians, community health centers and primary physicians. It's products include own produced instruments and disposable agents as well as blood analysis systems LifeAssays Reader and LifeAssays VetReader. The company was founded on August 17, 2000 and is headquartered in Lund, Sweden. | Health Technology |
| Preelumina Diagnostics AB | |
ImmuneBiotech Medical Sweden AB
ImmuneBiotech Medical Sweden AB Pharmaceuticals: MajorHealth Technology ImmuneBiotech Medical Sweden AB engages in the development of novel probiotics for therapeutic effects. It offers ImmuneBiotics, probiotics for achieving balance between the microbiome, the immune system, and the intestinal barrier. The company was founded by Shahram Lavasani and Mehrnaz Nouri and is headquartered in Lund, Sweden. | Health Technology |
Targinta AB
Targinta AB BiotechnologyHealth Technology Part of Xintela AB, Targinta AB develops targeting and toxin-armed antibodies for cancer. The private company is based in Lund, Sweden. Peter Ekolind has been the CEO of the Swedish company since 2022. | Health Technology |
| BioFinans AB | |
| Telepartner AS (Norway) |
